HomeCompareBIS vs JEPQ

BIS vs JEPQ: Dividend Comparison 2026

BIS yields 4.76% · JEPQ yields 11.47%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $18.5K in total portfolio value
10 years
BIS
BIS
● Live price
4.76%
Share price
$9.11
Annual div
$0.43
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.3K
Annual income
$645.71
Full BIS calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.47%
Share price
$53.77
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.8K
Annual income
$2,269.18
Full JEPQ calculator →

Portfolio growth — BIS vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBISJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIS + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIS pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIS
Annual income on $10K today (after 15% tax)
$404.66/yr
After 10yr DRIP, annual income (after tax)
$548.85/yr
JEPQ
Annual income on $10K today (after 15% tax)
$974.55/yr
After 10yr DRIP, annual income (after tax)
$1,928.80/yr
At 15% tax rate, JEPQ beats the other by $1,379.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIS + JEPQ for your $10,000?

BIS: 50%JEPQ: 50%
100% JEPQ50/50100% BIS
Portfolio after 10yr
$36.6K
Annual income
$1,457.45/yr
Blended yield
3.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIS buys
0
JEPQ buys
0
No recent congressional trades found for BIS or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBISJEPQ
Forward yield4.76%11.47%
Annual dividend / share$0.43$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$27.3K$45.8K
Annual income after 10y$645.71$2,269.18
Total dividends collected$5.6K$17.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: BIS vs JEPQ ($10,000, DRIP)

YearBIS PortfolioBIS Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$11,176$476.07$11,967$1,146.53$791.00JEPQ
2$12,456$497.25$14,216$1,268.02$1.8KJEPQ
3$13,845$517.93$16,774$1,392.20$2.9KJEPQ
4$15,353$538.05$19,667$1,518.21$4.3KJEPQ
5$16,985$557.59$22,925$1,645.21$5.9KJEPQ
6$18,750$576.52$26,578$1,772.40$7.8KJEPQ
7$20,658$594.81$30,656$1,899.04$10.0KJEPQ
8$22,716$612.44$35,194$2,024.45$12.5KJEPQ
9$24,936$629.41$40,228$2,148.01$15.3KJEPQ
10$27,327$645.71$45,796$2,269.18$18.5KJEPQ

BIS vs JEPQ: Complete Analysis 2026

BISStock

ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index.

Full BIS Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this BIS vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIS vs SCHDBIS vs JEPIBIS vs OBIS vs KOBIS vs MAINBIS vs XYLDBIS vs QYLDBIS vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.